An ultra scale‐down characterization of low shear stress primary recovery stages to enhance selectivity of fusion protein recovery from its molecular variants

Fusion proteins offer the prospect of new therapeutic products with multiple functions. The primary recovery is investigated of a fusion protein consisting of modified E2 protein from hepatitis C virus fused to human IgG1 Fc and expressed in a Chinese hamster ovary (CHO) cell line. Fusion protein products inevitably pose increased challenge in preparation and purification. Of particular concerns are: (i) the impact of shear stress on product integrity and (ii) the presence of product‐related contaminants which could prove challenging to remove during the high resolution purification steps. This paper addresses the use of microwell‐based ultra scale‐down (USD) methods to develop a bioprocess strategy focused on the integration of cell culture and cell removal operations and where the focus is on the use of operations which impart low shear stress levels even when applied at eventual manufacturing scale. An USD shear device was used to demonstrate that cells exposed to high process stresses such as those that occur in the feed zone of a continuous non‐hermetic centrifuge resulted in the reduction of the fusion protein and also the release of glycosylated intracellular variants. In addition, extended cell culture resulted in release of such variants. USD mimics of low shear stress, hydrohermetic feed zone centrifugation and of depth filtration were used to demonstrate little to no release during recovery of these variants with both results verified at pilot scale. Furthermore, the USD studies were used to predict removal of contaminants such as lipids, nucleic acids, and cell debris with, for example, depth filtration delivering greater removal than for centrifugation but a small (∼10%) decrease in yield of the fusion protein. These USD observations of product recovery and carryover of contaminants were also confirmed at pilot scale as was also the capacity or throughput achievable for continuous centrifugation or for depth filtration. The advantages are discussed of operating a lower yield cell culture and a low shear stress recovery process in return for a considerably less challenging purification demand. Biotechnol. Bioeng. 2013; 110: 1973–1983. © 2013 Wiley Periodicals, Inc.

[1]  M. Boychyn,et al.  Performance prediction of industrial centrifuges using scale-down models , 2004, Bioprocess and biosystems engineering.

[2]  H. Drummer,et al.  Hepatitis C Virus Glycoprotein E2 Contains a Membrane-proximal Heptad Repeat Sequence That Is Essential for E1E2 Glycoprotein Heterodimerization and Viral Entry* , 2004, Journal of Biological Chemistry.

[3]  Nigel J. Titchener-Hooker,et al.  Studies on membrane sterile filtration of plasmid DNA using an automated multiwell technique , 2010 .

[4]  P Dunnill,et al.  Micro biochemical engineering to accelerate the design of industrial‐scale downstream processes for biopharmaceutical proteins , 2008, Biotechnology and bioengineering.

[5]  Abhinav A. Shukla,et al.  Harvest and Recovery of Monoclonal Antibodies: Cell Removal and Clarification , 2008 .

[6]  A. Racher,et al.  Metabolic Rates, Growth Phase, and mRNA Levels Influence Cell-Specific Antibody Production Levels from In Vitro-Cultured Mammalian Cells at Sub-Physiological Temperatures , 2008, Molecular biotechnology.

[7]  H Baldascini,et al.  Rapid whole monoclonal antibody analysis by mass spectrometry: An Ultra scale‐down study of the effect of harvesting by centrifugation on the post‐translational modification profile , 2010, Biotechnology and bioengineering.

[8]  W Berthold,et al.  Assessment of a disc stack centrifuge for use in mammalian cell separation , 1995, Biotechnology and bioengineering.

[9]  M. Hoare,et al.  Ultra scale‐down prediction using microwell technology of the industrial scale clarification characteristics by centrifugation of mammalian cell broths , 2009, Biotechnology and bioengineering.

[10]  H. Prentice,et al.  Improving Performance of Mammalian Cells in Fed‐Batch Processes through “Bioreactor Evolution” , 2007, Biotechnology progress.

[11]  N. Slater,et al.  Characterisation of a generic monoclonal antibody harvesting system for adsorption of DNA by depth filters and various membranes , 1999, Bioseparation.

[12]  Simyee Kong,et al.  Large‐scale plasmid DNA processing: evidence that cell harvesting and storage methods affect yield of supercoiled plasmid DNA , 2008, Biotechnology and applied biochemistry.

[13]  J. Izard,et al.  Rapid screening method for quantitation of bacterial cell lipids from whole cells. , 2003, Journal of microbiological methods.

[14]  J. Bukh,et al.  Hypervariable Region 1 Differentially Impacts Viability of Hepatitis C Virus Strains of Genotypes 1 to 6 and Impairs Virus Neutralization , 2010, Journal of Virology.

[15]  P Dunnill,et al.  The use of laboratory centrifugation studies to predict performance of industrial machines: studies of shear-insensitive and shear-sensitive materials. , 2000, Biotechnology and bioengineering.

[16]  Roger Brunkow,et al.  The clarification of bioreactor cell cultures for biopharmaceuticals , 2003 .

[17]  A. Dell,et al.  Glycoprotein Structure Determination by Mass Spectrometry , 2001, Science.

[18]  C. Rice,et al.  Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies. , 2007, Vaccine.

[19]  Abhinav A Shukla,et al.  Recent advances in large-scale production of monoclonal antibodies and related proteins. , 2010, Trends in biotechnology.

[20]  Seppo Ylä-Herttuala,et al.  Challenges in monoclonal antibody-based therapies , 2009, Annals of medicine.

[21]  William Kelly,et al.  Modeling Shear Damage to Suspended CHO Cells during Cross‐Flow Filtration , 2007, Biotechnology progress.

[22]  T. Tedder,et al.  Type I (CD64) and type II (CD32) Fc gamma receptor-mediated phagocytosis by human blood dendritic cells. , 1996, Journal of immunology.

[23]  N Hutchinson,et al.  Shear stress analysis of mammalian cell suspensions for prediction of industrial centrifugation and its verification , 2006, Biotechnology and bioengineering.

[24]  Chichi Huang,et al.  Receptor-Fc fusion therapeutics, traps, and MIMETIBODY technology. , 2009, Current opinion in biotechnology.

[25]  Mayur G. Jain,et al.  Using CFD to understand how flow patterns affect retention of cell-sized particles in a tubular bowl centrifuge , 2005 .

[26]  C. Colaco,et al.  Adjuvant-Free Immunization with Hemagglutinin-Fc Fusion Proteins as an Approach to Influenza Vaccines , 2010, Journal of Virology.

[27]  Klaus Tarrach,et al.  Depth filtration: Cell clarification of bioreactor offloads , 2006 .

[28]  Michael W. Laird,et al.  Identification and prevention of antibody disulfide bond reduction during cell culture manufacturing , 2010, Biotechnology and bioengineering.

[29]  Abhinav A Shukla,et al.  Exploitation of the Adsorptive Properties of Depth Filters for Host Cell Protein Removal during Monoclonal Antibody Purification , 2006, Biotechnology progress.

[30]  Brian D. Kelley,et al.  DOWNSTREAM PROCESSING OF MONOCLONAL ANTIBODIES: CURRENT PRACTICES AND FUTURE OPPORTUNITIES , 2008 .

[31]  W. Berthold,et al.  Clarification of animal cell cultures on a large scale by continuous centrifugation , 2005, Journal of Industrial Microbiology.

[32]  A. Zydney,et al.  Scale-up of microfiltration systems: fouling phenomena and Vmax analysis☆ , 2002 .

[33]  Charles M. Ambler.  The theory of scaling up laboratory data for the sedimentation type centrifuge , 1959 .

[34]  Gary J. Lye,et al.  An automated microscale technique for the quantitative and parallel analysis of microfiltration operations , 2006 .

[35]  David W. Roush,et al.  Impact of Cell Density and Viability on Primary Clarification of Mammalian Cell Broth An Analysis Using Disc-Stack Centrifugation and Charged Depth Filtration , 2007 .

[36]  Mike Hoare,et al.  Characterization of flow intensity in continuous centrifuges for the development of laboratory mimics , 2001 .

[37]  F. Wurm.  Production of recombinant protein therapeutics in cultivated mammalian cells , 2004, Nature Biotechnology.